• SIRT3-SUMO Regulation of Treg Cells in Asthma

  2026-10-06

  Hu and Liu link SIRT3-SUMO regulation with fatty acid oxidation, hexosamine biosynthetic pathway activity, N-glycosylation, and regulatory T-cell differentiation in asthma models. The study offers a mechanistic framework for interpreting immunometabolic control of asthma, while its model-specific design means that clinical translation remains to be established.

• Sex Differences in Angiotensin II Hypertension

  2026-10-06

  Xue, Pamidimukkala, and Hay showed that chronic Angiotensin II exposure produced a substantially larger blood-pressure increase in male than female conscious mice, while gonadectomy shifted these responses in opposite directions. The study is important because it links sex-dependent hypertension not only to pressure magnitude, but also to baroreflex regulation and sympathetic contributions.

• Octenidine: Research Context and Evidence

  2026-10-05

  A source-grounded overview of octenidine dihydrochloride, covering its chemical identity, membrane-disruptive rationale, comparative antimicrobial findings, conceptual research applications, evidence strength, and important limits on interpretation.

• Angiotensin II: Five Evidence Questions

  2026-10-05

  A source-grounded overview of Angiotensin II biology, evidence quality, interpretation, research scope, and limitations, with particular attention to vascular smooth muscle cells, inflammation, aneurysm biology, and the distinction between mechanistic findings and clinical conclusions.

• Oteseconazole: Translational Precision in CYP51 Science

  2026-10-04

  Oteseconazole (VT-1161) illustrates how selective fungal CYP51 inhibition can connect molecular mechanism, Candida-focused activity, and translational decision-making. This thought-leadership analysis separates supplier-reported product data from findings in a 2025 deuterated tetrazole study, clarifies evidence boundaries, and outlines research questions for antifungal development.

• Procainamide Hydrochloride: Research Evidence

  2026-10-03

  Procainamide Hydrochloride is best understood as a pharmacology research compound with established cardiac electrophysiology relevance and emerging, more limited evidence in oncology, immunology, and epigenetics. This overview examines its cardiac sodium channel context, the published cisplatin–liposome study, reported antiproliferative findings, evidence strength, and the boundaries that prevent direct translation to clinical treatment.

• Triptolide in Pancreatitis: A Mechanistic Assay Guide

  2026-10-02

  Triptolide, also known as PG490, connects transcriptional suppression, immune-cell apoptosis, cancer invasion phenotypes, and acute pancreatitis research. This guide focuses on how to interpret its pathway activity, design defensible assays, and distinguish mechanistic evidence from translational speculation.

• Annexin V-APC/7-AAD Apoptosis Kit Workflow

  2026-10-01

  Build a rapid two-parameter workflow that distinguishes viable, early apoptotic, late apoptotic, and membrane-compromised cells. The assay is especially useful for testing tumor–immune interactions, including the apoptosis consequences of checkpoint disruption in clear cell renal cell carcinoma models.

• Ribonuclease R for Circular RNA Workflows

  2026-10-01

  Use Ribonuclease R to remove linear RNA before circular RNA validation, sequencing, and stability experiments. This practical workflow connects RNase R resistance testing with the circHIF1A/miR-486-5p/GRHL2 findings in lung adenocarcinoma research while emphasizing controls, assay limits, and troubleshooting.

• LY2603618: Practical Chk1 Inhibitor Workflows

  2026-09-30

  LY2603618 enables mechanism-led studies of checkpoint failure, DNA damage accumulation, and chemotherapy sensitization in cancer models. This guide translates its reported activity into practical cell-cycle, combination-treatment, assay-selection, and troubleshooting workflows while distinguishing established evidence from exploratory applications.

• Bradykinin BA5201: Practical Research Workflow

  2026-09-30

  Bradykinin BA5201 provides a defined research peptide for controlled studies of endothelium-dependent vasodilation, vascular permeability, smooth muscle responses, pain mechanisms, and inflammation signaling. It is intended for short-duration experimental workflows, not diagnostic or medical use, and its solutions should not be stored long term.

• Octenidine Dihydrochloride Research Guide

  2026-09-29

  Octenidine dihydrochloride is a synthetic cationic antiseptic small molecule used for antimicrobial research. Its documented membrane-disruptive mechanism, defined physicochemical specifications, and research-only status make it suitable for controlled laboratory workflows rather than direct clinical inference.

• Chlorpromazine HCl in Mechanistic Cell Assays

  2026-09-29

  Chlorpromazine HCl gives researchers a practical dopamine receptor antagonist for connecting receptor pharmacology with electrophysiology, calcium signaling, and carefully controlled endocytosis experiments. This guide translates the reference study on electrical stimulation and magnetic nanoparticles into assay-ready workflows while separating established evidence from exploratory cross-domain applications.

• Thermal Shift Assays for Bacterial Sensor Ligands

  2026-09-28

  Monteagudo-Cascales and colleagues review how thermal shift assays can reveal ligands for bacterial receptor domains while emphasizing pH optimization, assay artifacts, and orthogonal binding validation. The study positions TSA as a scalable discovery method, but shows that thermal stabilization alone is not sufficient to establish direct or physiologically relevant binding.

• ALC-0159 and the Next Generation of mRNA LNPs

  2026-09-28

  A translational perspective on where ALC-0159 fits in mRNA lipid nanoparticle design—and how new evidence on pH-responsive zwitterionic lipids should shape formulation decisions, experimental controls, and expectations for cancer vaccine research.

8156 records 1/544 page Next 12345 下5页 Last page